|
⚲
|
| Keyboard |
| Dinerman Michael
✚
|
|
|---|---|
| CIK # | 0001614589 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001614589] | |
| 4 | [0001614589] | |
| SC 13G | [0001614589] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Dinerman Michael | Viking Therapeutics Inc | [2016-02-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dinerman Michael | |
| Viking Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Tax withheld | 8,724 | $9.49 | 82,791 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Conversion | 3,642 | ||
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Grant | 105,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Disposed to issuer | 998,250 | ||
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2015-05-04 | Grant | 45,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Convertible Note due 2015 · derivative
|
2015-05-04 | Conversion | $0.00 |